Glucosamine Sulphate in Osteoarthritis: From Symptoms to Structure Modification

Author(s): Jean-Yves Reginster, Marie-Paule Lecart, Olivier Bruyere, Nansa Burlet.

Journal Name: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Continued as Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Volume 4 , Issue 3 , 2005


Several chemical entities have been carefully investigated for the symptomatic and structural management of osteoarthritis. The most compelling evidence of a potential for inhibiting the structural progression of osteoarthritis has been obtained with glucosamine sulfate. At any rate, this compound has clearly demonstrated a symptomatic action, mainly in osteoarthritis of the lower limbs, on pain relief and improvement of functional disability. An important issue is that all the conclusive studies with such chemical entities resulted from the use of prescription medicines and not over-thecounter pills of food supplements.

Keywords: aminosaccharide, glycosaminoglycan, cartilage, osteoarthritic chondrocytes, proteoglycans, rat chondrosarcoma cell line, spinal localizations, ibuprofen, narrowest joint space (njs)

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [217 - 220]
Pages: 4
DOI: 10.2174/1568014054065212
Price: $58

Article Metrics

PDF: 2